Skip to main content

Table 2 Expression of markers and survival.

From: Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas

   

Tumor

   

Peritumoral capsule

 

Marker expression

Patients (n)

Patients (%)

Median survival (months)

5-Year survival (%)

P

Patients (n)

Patients (%)

Median survival (months)

5-Year survival (%)

P

CD 3

          

Low

56

70

80

54

0.207

29

36

32

47

0.756

High

19

24

27

36

 

40

50

67

56

 

Missing

5

6

   

11

14

   

CD 4

          

Low

64

80

57

49

0.887

45

56

52

51

0.654

High

14

18

27

50

 

35

44

57

53

 

Missing

2

3

   

10

12

   

CD 8

          

Low

64

80

80

54

0.198

47

59

67

52

0.838

High

14

18

15

36

 

26

32

38

50

 

Missing

2

3

   

7

9

   

CD 20

          

Low

56

70

63

50

0.880

65

81

75

55

0.032

High

22

28

32

50

 

12

15

13

33

 

Missing

2

3

   

3

4

   
  1. Peritumoral capsule lymphocyte subsets and their prediction for disease-specific survival in patients with soft tissue sarcomas (univariate analysis; log-rank test), N = 80
Back to article page

BMC Clinical Pathology

ISSN: 1472-6890

Contact us